In a randomized, double-blind, placebo-controlled study over 6 months in overweight but otherwise healthy adults, supplementation with Moro blood orange extract was associated with significantly greater improvements in body mass, BMI, waist circumference, hip circumference, and fat distribution (including both visceral and subcutaneous fat) compared to placebo
Specific GLP-1 agents have been shown to improve cardiovascular outcomes, and liraglutide, semaglutide (subcutaneous and oral), dulaglutide, and albiglutide consistently reduce the risk of MACE in people with T2D with established CVD or a high risk of CVD
555 Allelic variations of the APOE gene may be the greatest genetic risk for AD
the October 2024 Westminster Hall debate (Cat Smith MP) and PoTS UK Parliamentary Campaign 2025